Metabolic Syndrome in Older HIV-Infected Patients: Data from the CORE50 Cohort

被引:29
作者
Adeyemi, Oluwatoyin [1 ]
Rezai, Katayoun [1 ]
Bahk, Mieoak [1 ]
Badri, Sheila [1 ]
Thomas-Gossain, Neena [1 ]
机构
[1] Rush Univ, Med Ctr, Stroger Hosp Cook Cty, Dept Internal Medicine Infect Dis,CORE Ctr, Chicago, IL 60612 USA
关键词
D O I
10.1089/apc.2008.0119
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Metabolic abnormalities and cardiovascular disease are increasingly recognized in HIV-infected patients. While HIV-infected patients older than 50 years of age account for up to 25% of HIV cases in the United States, there are limited data on these individuals. To determine the prevalence and predictors of the metabolic syndrome among a cohort of older, HIV-infected patients and to calculate their 10-year Framingham cardiac risk (FCR) score a cross-sectional study of HIV patients older than 50 years of age was conducted at the CORE Center, Chicago, Illinois, between May 2005 and February 2006. There were 121 HIV-infected patients with a median age of 54 years, of whom 79% were male, 83% African American, 9% Hispanic, and 6% Caucasian. Thirty-four percent of patients had the metabolic syndrome, 49% had a moderate -high (>10%) 10-year FCR, and 13% had a high (>20%) 10-year FCR. Patients with the metabolic syndrome were significantly more likely to have a greater than 20% 10-year FCR. Sixty-five percent of all patients were current smokers and 55% of patients with the metabolic syndrome were current smokers. There were significant differences in the components of the metabolic syndrome by gender with women having significantly more components related to insulin resistance such as elevated waist circumference and diabetes, while men were more likely to have low high-density lipoprotein (HDL) levels. This study shows a high prevalence of the metabolic syndrome in older HIV-infected patients and an association between the metabolic syndrome and FCR in our study population. As the HIV population ages, attention to modifiable cardiac risk factors will become increasingly important.
引用
收藏
页码:941 / 945
页数:5
相关论文
共 18 条
[1]   A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].
Carr, A ;
Samaras, K ;
Burton, S ;
Law, M ;
Freund, J ;
Chisholm, DJ ;
Cooper, DA .
AIDS, 1998, 12 (07) :F51-F58
[2]   Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy:: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group [J].
Dubé, MP ;
Stein, JH ;
Aberg, JA ;
Fichtenbaum, CJ ;
Gerber, JG ;
Tashima, KT ;
Henry, WK ;
Currier, JS ;
Sprecher, D ;
Glesby, MJ .
CLINICAL INFECTIOUS DISEASES, 2003, 37 (05) :613-627
[3]   Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359
[4]   Cardiovascular disease risk factors in HIV patients -: association with antiretroviral therapy.: Results from the DAD study [J].
Friis-Moller, N ;
Weber, R ;
Reiss, P ;
Thiébaut, R ;
Kirk, O ;
Monforte, AD ;
Pradier, C ;
Morfeldt, L ;
Mateu, S ;
Law, M ;
El-Sadr, W ;
De Wit, S ;
Sabin, CA ;
Phillips, AN ;
Lundgren, JD .
AIDS, 2003, 17 (08) :1179-1193
[5]   Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort Study [J].
Glass, T. R. ;
Ungsedhapand, C. ;
Wolbers, M. ;
Weber, R. ;
Vernazza, P. L. ;
Rickenbach, M. ;
Furrer, H. ;
Bernasconi, E. ;
Cavassini, M. ;
Hirschel, B. ;
Battegay, M. ;
Bucher, H. C. .
HIV MEDICINE, 2006, 7 (06) :404-410
[6]   Smoking behavior in a low-income multiethnic HIV/AIDS population [J].
Gritz, ER ;
Vidrine, DJ ;
Lazev, AB ;
Amick, BC ;
Arduino, RC .
NICOTINE & TOBACCO RESEARCH, 2004, 6 (01) :71-+
[7]   Definition of metabolic syndrome - Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition [J].
Grundy, SM ;
Brewer, HB ;
Cleeman, JI ;
Smith, SC ;
Lenfant, C .
CIRCULATION, 2004, 109 (03) :433-438
[8]   Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy [J].
Hadigan, C ;
Meigs, JB ;
Corcoran, C ;
Rietschel, P ;
Piecuch, S ;
Basgoz, N ;
Davis, B ;
Sax, P ;
Stanley, T ;
Wilson, PWF ;
D'Agostino, RB ;
Grinspoon, S .
CLINICAL INFECTIOUS DISEASES, 2001, 32 (01) :130-139
[9]   Cardiovascular morbidity and mortality associated with the metabolic syndrome [J].
Isomaa, B ;
Almgren, P ;
Tuomi, T ;
Forsén, B ;
Lahti, K ;
Nissén, M ;
Taskinen, MR ;
Groop, L .
DIABETES CARE, 2001, 24 (04) :683-689
[10]   Metabolic syndrome among HIV-infected patients -: Prevalence, characteristics, and related factors [J].
Jericó, C ;
Knobel, H ;
Montero, M ;
Ordoñez-Llanos, J ;
Guelar, A ;
Gimeno, JL ;
Saballs, P ;
López-Colomés, JL ;
Pedro-Botet, J .
DIABETES CARE, 2005, 28 (01) :132-137